参考文献/References:
[1]Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.[2]中华医学会呼吸病学分会肺癌学组,中国肺癌防治联盟专家组.肺部结节诊治中国专家共识[J].中华结核和呼吸杂志,2015,38(4):249-254.[3]Detterbeck FC,Boffa DJ,Kim AW,et al.The eighth edition lung cancer stage classification[J].Chest,2017,151(1):193-203.[4]周清华,范亚光,王颖.中国肺部结节分类、诊断与治疗指南(2016年版)[J]中国肺癌杂志,2016,19(12):793-798.[5]余翔,张敏,刘建光.孤立性肺结节影像学特征的logistic回归分析[J].蚌埠医学院学报,2019,44(7):936-939.[6]Macmahon H,Naidich DP,Goo JM,et al.Guidelines for management of incidental pulmonary nodules detected on CT images:from the Fleischner ociety 2017[J].Radiology,2017,284(1):228-243.[7]Varoli F,Vergani C,Caminiti R,et al.Management of solitary pulmonary nodule[J].Ear J Cardiothorae Surg,2008,33(3):461-465.[8]刘慧,李永怀,桂淑玉.肺癌患者血清肿瘤标记物检测的临床意义及预后评估[J].临床肺科杂志,2014,19(12):2219-2222.[9]Chu XY,Hou XB,Song WA,et al.Diagnostic values of SCC, CEA,Cyfra21-1 and NSE for lung Cancer in patients with suspicious pulmonary:a single center analysis[J].Cancer Biol Ther,2011,11(12):995-1000.[10]Horinouchi H.Anti-vascular endothelial growth factor therapies at the crossroads:linifanib for non-small cell lung cancer[J].Trans1 Lung Cancer Res,2016,5(1):78-81.[11]马进林,马晓艳,王海强.肺癌孤立性肺结节患者64排螺旋CT扫描影像特点分析[J].中华肺部疾病杂志(电子版),2021,14(1):48-52.[12]Cho A,Hur J,Moon YW,et al.Correlation between EGFR gene mutation.cytologic tumor markers.18F-FDG uptake in non-small cell lung cancer[J].BMC Cancer,2016(16):224-232.[13]李艳萍,殷俊.血清肿瘤标志物与肺癌高危因素的临床分析[J].中华肺部疾病杂志(电子版),2017,10(3):321-324.[14]李笑莹,刘芳,车海杰,等.肿瘤标志物预测孤立性肺结节恶性概率模型的建立与初步评价[J].山东大学学报,2017,55(4):60-64.[15]雷晴,彭波,龙飞,等.孤立性肺结节与肿瘤标记物动态水平的相关性研究[J].四川医学,2016,37(6):588-591.[16]李四香,李镭,杨茗,等.肺癌患者血常规指标特征分析[J].华西医学,2020,35(9):1060-1067.[17]Hanahan D,Weinberg RA.Hallmarks of cancer: the next generation[J].Cell,2011,144(5):646-674.[18]Fulkerson PC.Transcription Factors in Eosinophil Development and As Therapeutic Targets.Front Med (Lausanne),2017(4):115.[19]Weller PF,Spencer LA.Functions of tissue-resident eosinophils[J].Nat Rev Immunol,2017,17(12):746-760.
相似文献/References:
[1]张铁彪,刘建华,马长顺.肺癌肿瘤标记物结合胸部CT检查肺结节的定性分析[J].医学信息,2022,35(10):171.[doi:10.3969/j.issn.1006-1959.2022.10.044]
ZHANG Tie-biao,LIU Jian-hua,MA Chang-shun.Qualitative Analysis of Lung Cancer Tumor Markers Combined with Chest CT Examination of Pulmonary Nodules[J].Medical Information,2022,35(03):171.[doi:10.3969/j.issn.1006-1959.2022.10.044]
[2]韦能宝,薛志刚,毕金文.尿源性脓毒血症诊治分析[J].医学信息,2018,31(24):170.[doi:10.3969/j.issn.1006-1959.2018.24.052]
WEI Neng-bao,XUE Zhi-gang,BI Jin-wen.Diagnosis and Treatment of Urinary Sepsis[J].Medical Information,2018,31(03):170.[doi:10.3969/j.issn.1006-1959.2018.24.052]
[3]邓燕云,覃丽兰,黄晓琪.PET/CT功能影像引导肺部结节性病变穿刺活检的研究进展[J].医学信息,2022,35(14):147.[doi:10.3969/j.issn.1006-1959.2022.14.038]
DENG Yan-yun,QIN Li-lan,HUANG Xiao-qi.Research Progress of PET/CT Functional Imaging Guided Biopsy of Pulmonary Nodular Lesions[J].Medical Information,2022,35(03):147.[doi:10.3969/j.issn.1006-1959.2022.14.038]
[4]张 蕊,任 徽.CT引导下经皮肺穿刺活检术诊断肺占位病变的研究[J].医学信息,2019,32(17):97.[doi:10.3969/j.issn.1006-1959.2019.17.030]
ZHANG Rui,REN Hui.The Value of CT-guided Percutaneous Lung Biopsy in the Diagnosis of
Pulmonary Space-occupying Lesions[J].Medical Information,2019,32(03):97.[doi:10.3969/j.issn.1006-1959.2019.17.030]
[5]徐涑珅,石昌国,张晓伟.同期与分期肺结节手术对双侧肺结节患者术后肺功能及血气指标的影响[J].医学信息,2022,35(04):137.[doi:10.3969/j.issn.1006-1959.2022.04.035]
XU Su-shen,SHI Chang-guo,ZHANG Xiao-wei.Effects of Simultaneous and Staged Pulmonary Nodule Surgery on Postoperative Pulmonary Function and Blood Gas Indexes in Patients with Bilateral Pulmonary Nodules[J].Medical Information,2022,35(03):137.[doi:10.3969/j.issn.1006-1959.2022.04.035]
[6]周国华,李建伟,沈海平,等.基于BMI的正位定位像技术在个性化低剂量CT肺结节筛查中应用价值[J].医学信息,2025,38(18):42.[doi:10.3969/j.issn.1006-1959.2025.18.009]
ZHOU Guohua,LI Jianwei,SHEN Haiping,et al.Application Value of BMI-based Anteroposterior Positioning Technologyin Personalized Low-dose CT Screening for Lung Nodule[J].Medical Information,2025,38(03):42.[doi:10.3969/j.issn.1006-1959.2025.18.009]